Paul Brennan, PhD, is the Head of the Genetics Section of the International Agency for Research on Cancer (IARC/WHO), Lyon, France. The research focus of his group has two primary aims:
- identifying cancer predisposition genes through either genotyping or sequencing of very large numbers of cases and controls
- using biomarkers to help identify non-genetic risk factors for cancer, and even help identify early stage cancers.
His group works with colleagues in many different parts of the world, with active field work studies underway in central and eastern Europe, central and south-east Asia, and Latin America.